HR. 1082In Committee
Shandra Eisenga Human Cell and Tissue Product Safety Act
Plain-English overview
What this bill does
Establishes civil penalties and FDA reporting and education requirements for regulation of human cell and tissue products
Key points
- Establish civil penalties
- Require FDA workshops
- Require FDA reports
- Require FDA educational materials
Current status
Where it stands
Status
In Committee
Latest action
2025-06-24 — Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.